Text or call a human:Text (808) 600-9260Call
CorporateVentureCapital.com

Bristol Myers Squibb

Corporate venture profile

Parent Bristol Myers SquibbHQ Princeton, United States

This profile covers the startup investments made by Bristol Myers Squibb, a pharmaceutical and biotech company. It is based in Princeton, United States. It invests from Series A to Series C+. Sectors it names: biotech and life sciences.

Every figure links to its source

Snapshot

Investment stage: Series A to Series C+
Data behind this graphic
Data behind this graphic
ItemValue
Stage rangeSeries A to Series C+
SectorsBiotech and life sciences
GeographyNorth America
OfficesPrinceton, United States

Sources: S2 Fierce Biotech: Aktis bags USD 72M Novartis and BMS-backed Series A.

Graphic 1 of 1

Investment stage: Series A to Series C+

Sources: S2 Fierce Biotech: Aktis bags USD 72M Novartis and BMS-backed Series A.

Download:Report a correction

Where it invests

Geography

Headquarters
Princeton, United States
Offices
  • Princeton, United States

Investment regionsS2

Key facts

FactValueStatusSource
Parent companyBristol Myers Squibb (NYSE: BMY)Single sourceS1
Parent industryPharmaceuticals and biotechSingle sourceS1
HeadquartersPrinceton, United StatesSingle sourceS4
Capital sourceParent company onlySingle sourceS1
StagesSeries A, Series B, Series C+Single sourceS2

About Bristol Myers Squibb

ItemDetailSource
Listed asNYSE: BMYS1
HeadquartersUnited StatesS1

History

  1. Participated in USD 72M Series A (March)S2
  2. Participated in USD 220M Series B (September); investor in USD 325M Series C (2024)S3

Portfolio

Portfolio companies named in public sources: Aktis Oncology, ArsenalBio.S2

Shared portfolio with other corporate VCs

2 companies on the Bristol Myers Squibb portfolio page also appear on the portfolio page of at least one other firm in this directory. Matched by company website, or by name where no website is published.

FirmSharedCompanies in common
MRL Ventures Fund1Aktis Oncology
Hitachi Ventures1ArsenalBio

Companies backed by the most corporate VCs

Official pages

Read the firm's own pages for current information.

Sources

  1. S1Bristol Myers Squibb: areas of interest for partnerships and business developmentFirm
  2. S2Fierce Biotech: Aktis bags USD 72M Novartis and BMS-backed Series APress
  3. S3Arsenal Bio: announces USD 325M financing (4 Sep 2024)Press
  4. S4SEC EDGAR submissions: Bristol Myers Squibb business addressFiling

Disclaimer and corrections

Not affiliated. This page is not affiliated with, endorsed by or sponsored by Bristol Myers Squibb or any company named on it. Names and trademarks belong to their owners. Informational only. This is a public-source reference. It is not investment, legal or tax advice and not an offer or solicitation. Sources. Each figure names its source. Figures may have changed. Please read the firm's official pages, linked above. Corrections and takedown. To report an error or ask for a change or removal, use the correction form or email Richard@CorporateVentureCapital.com.

Spotted a mistake? Report a correction.